454 results
8-K
EX-10.1
ORKA
Oruka Therapeutics Inc.
4 Oct 24
Departure of Directors or Certain Officers
4:05pm
following the calendar year to which such bonus relates.
4. Benefits/Paid Time Off. You will continue to be eligible, subject to the terms … of the applicable plans and programs, to participate in the employee benefits and insurance programs generally made available to the Company’s full-time employees
8-K
EX-10.2
ORKA
Oruka Therapeutics Inc.
4 Oct 24
Departure of Directors or Certain Officers
4:05pm
annual bonus will be paid no later than March 15th of the calendar year following the calendar year to which such bonus relates.
4. Benefits/Paid … Time Off. You will continue to be eligible, subject to the terms of the applicable plans and programs, to participate in the employee benefits
8-K
ORKA
Oruka Therapeutics Inc.
4 Oct 24
Departure of Directors or Certain Officers
4:05pm
changes, the Amended Agreements revised each executive’s potential severance benefits and payments.
Under Dr. Klein’s Amended Agreement, in the event
8-K
EX-10.1
ORKA
Oruka Therapeutics Inc.
13 Sep 24
Oruka Therapeutics Announces $200 Million Private Placement
4:02pm
, vacation pay, salary continuation for disability, retirement benefits, deferred compensation, bonus pay, incentive pay, stock options or other stock … and its Subsidiaries have taken all reasonable steps to protect, maintain and safeguard their Intellectual Property.
3.13 Employee Benefits. Except
8-K
EX-10.2
ORKA
Oruka Therapeutics Inc.
13 Sep 24
Oruka Therapeutics Announces $200 Million Private Placement
4:02pm
), or (iii) file a general consent to service of process in any such jurisdiction.
(j) Rule 144. With a view to making available to the Investors the benefits
8-K
EX-99.2
sxxvsueenw5h2k3nggoa
13 Sep 24
Oruka Therapeutics Announces $200 Million Private Placement
4:02pm
8-K
h9e cj2rgnmyklj2u
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-10.11
r9j v0mtawq8n
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-99.4
y9qtx
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-10.10
ahcmkvprzs5nhysjhvg7
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-10.25
vl5z9
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-99.3
g7r7xy 4mzh
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-14.1
ga5cr
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-10.16
0ftpskv3ll3 gumxdqvq
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-99.1
durn4 m017
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
425
EX-99.1
tkca1 fljz
26 Aug 24
Business combination disclosure
7:53pm
425
eopaf
26 Aug 24
Business combination disclosure
7:53pm
8-K
jd8g4prr3
26 Aug 24
ARCA biopharma Provides Update Regarding Special Dividend Amount in Connection with the Proposed Merger with Oruka Therapeutics
7:51pm
8-K
EX-99.1
a73bnfp7ixbuqx
26 Aug 24
ARCA biopharma Provides Update Regarding Special Dividend Amount in Connection with the Proposed Merger with Oruka Therapeutics
7:51pm
8-K
EX-99.1
us50emlrhzq3vw
23 Aug 24
ARCA biopharma Announces 1-for-12 Reverse Stock Split in Connection with the Proposed Merger with Oruka Therapeutics
4:35pm